Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomesRandomized Controlled Trial Published on 2022-09-012022-10-05 Journal: European journal of internal medicine [Category] COVID19(2023년), SARS, 임상, [키워드] affected airway anticoagulation clinical trial coronavirus coronavirus disease COVID-19 depressive symptom Depressive symptoms disease Exercise limitation Follow-up form functional Health Hospitalization ICU ICU patient impair IMPROVE intensive care intermediate limitation mental health multiple organ failure Odds ratio outcome outcomes participated Patient Patient health questionnaire-2 patients died patients with COVID-19 PHQ-2 Prophylactic prophylactic anticoagulation proportion Randomized Randomized controlled trial randomized patient Standard-dose Survivors The post-COVID-19 functional status scale. trial participants with COVID-19 women [DOI] 10.1016/j.ejim.2022.06.014 PMC 바로가기 [Article Type] Randomized Controlled Trial
Coagulation Abnormalities and Management in Hospitalized Pediatric Patients With COVID-19COVID-19로 입원한 소아 환자의 응고 이상 및 관리Article Published on 2022-07-012022-09-11 Journal: The Pediatric Infectious Disease Journal [Category] COVID19(2023년), SARS, 치료기술, [키워드] Abnormalities abnormality Anticoagulant anticoagulation Antithrombotic association change children Clinical outcome Coagulation coronavirus disease Coronavirus disease 2019 Course COVID-19 D-dimer level discharge enrolled Evidence Hospitalized hospitalized patient incidence increased risk initiated lack management median median age normalization outcome Patient patients pediatric Population Prophylactic prophylactic anticoagulation Prophylaxis Prospective Study risk risk factor selected severe cases severe COVID-19 severity tendency the disease thromboembolic Thromboembolic event Thromboembolic events Thromboprophylaxis thrombotic thrombotic complication Thrombotic complications Venous Thromboembolism VTE was performed with COVID-19 [DOI] 10.1097/INF.0000000000003545 PMC 바로가기 [Article Type] Article
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management응급 및 중환자 진료의를 위한 COVID-19에 대한 임상 업데이트: 의료 관리Review Published on 2022-06-012022-09-11 Journal: The American journal of emergency medicine [Category] COVID19(2023년), SARS, 임상, 치료제, [키워드] 2019 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Admitted Patient antagonists antivirals Aspirin Care caused Chloroquine clinical clinician Clinicians Colchicine concerning convalescent plasma coronavirus coronavirus disease Coronavirus-2019 COVID-19 Critical care demonstrated disease Emergency Famotidine help Hydroxychloroquine IMPROVE interleukin interleukin-6 introduced Ivermectin kinase inhibitors management mineral Minerals monoclonal antibodies morbidity and mortality outcomes Outpatient outpatients pandemic Patient patients progressed prophylactic anticoagulation provide Randomized respiratory SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Steroids Therapies therapy utility variety Vitamin vitamins with COVID-19 [DOI] 10.1016/j.ajem.2022.03.036 PMC 바로가기 [Article Type] Review
The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials고강도 항응고제 투여가 COVID-19 입원 환자의 임상 결과에 미치는 영향: 무작위 대조 시험의 메타 분석Meta-Analysis Published on 2022-02-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI 95% confidence interval Analysis Anticoagulant anticoagulation bleeding clinical benefit Clinical outcome clinical outcomes controlled trials Course COVID-19 database enoxaparin Evidence heparin hospitalized patient hospitalized patients identify major bleeding major bleeding event major bleeding events meta-analyses Meta-analysis Mortality no significant difference no statistically significant difference Odds ratio outcome Patient Prophylactic prophylactic anticoagulation random-effects model Random-effects models Randomized controlled trial Randomized controlled trials severe COVID-19 significantly increased statistically significant difference statistically significant reduction subgroup analysis systematic literature search therapeutic anticoagulation Thromboembolism thrombotic thrombotic event Thrombotic events was performed were used with COVID-19 [DOI] 10.1016/j.jiac.2021.11.008 PMC 바로가기 [Article Type] Meta-Analysis
Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review입원한 COVID-19 양성 환자의 혈전성 환경, 혈전성 사건 및 예방적 항응고제: 검토Review Published on 2022-01-012022-09-11 Journal: Clinical and applied thrombosis/hemostasis : offic [Category] 바이오마커, [키워드] Activation anticoagulation anticoagulation therapy Antithrombotic antithrombotic therapy Coagulation Coagulation parameters coagulation pathways Cohort Consensus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 disease Critically ill critically ill patients cytokine cytokine release D-dimer D-dimer level described disease elevated Endothelial dysfunction Evidence Guidance incidence indicated initial intensity milieu morbidity and mortality pandemic pathophysiology Pathways patients patients with COVID-19 Post-mortem Preliminary data pro-inflammatory cytokine release Prophylactic prophylactic anticoagulation Randomized controlled trials respiratory Respiratory illness review risk SARS-CoV2 severe respiratory illness suggested therapeutic anticoagulation therapy thromboembolic thromboembolic complication thromboembolic complications Thromboembolic event Thromboembolic events Thromboembolism thrombosis [DOI] 10.1177/10760296221074353 PMC 바로가기 [Article Type] Review
Symptomatic Carotid Artery Thrombosis in a Patient Recently Recovered From a COVID-19 InfectionCardiac/Thoracic/Vascular Surgery Published on 2021-10-092022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute illness angiography anticoagulation Arterial hypertension arteries arteriotomy Artery Asymptomatic COVID-19 atherosclerotic carotid carotid artery Carotid Artery Thrombosis carotid thrombectomy caused change China complications complications of COVID-19 Computed tomography consolidation Coronavirus disease 2019 cough Course COVID-19 COVID-19 infection CT scan CTA Cytokine storm diarrhea disease Dyspnoea Factor hypercoagulability IgG antibodies independent indicated Ischemic Stroke lower limb lung tissue Lungs male nausea Patient prophylactic anticoagulation quantitative antibody test recovered repeated risk factor SARS-CoV-2 scale severity Spread stroke Symptom thrombosis thrombotic complication Thrombus Vascular vessel vomiting was obtained was performed weakness widespread [DOI] 10.7759/cureus.18626 PMC 바로가기 [Article Type] Cardiac/Thoracic/Vascular Surgery
Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trialClinical Trial Published on 2021-08-012022-10-05 Journal: American heart journal [Category] 임상, [키워드] Acute myocardial infarction administration Analysis anticoagulation Antigen approved Biomarkers bleeding clinical investigation Clinical outcome Clinical practice clinical trial clinically Coalition COVID-19 Brazil collected coronavirus disease COVID-19 criteria D-dimer level D-dimer levels diagnosis of COVID-19 Disease progression disease severity Efficacy elevated evaluate events feasible Hierarchical higher risk Hospital stay Hospitalization hospitalized COVID-19 patient hospitalized patient IgM test IMPROVE In-hospital incidence include limb mandatory Mortality multicenter observational study Open-label outcome Oxygen therapy Patient patients Pragmatic Prevent Primary outcome Prognostic marker progression Prophylactic prophylactic anticoagulation Prophylaxis randomization Randomized rationale regimen RT-PCR SARS-CoV2 secondary Society stability Standard of care Strategy stratified stroke suggested Symptom therapeutic anticoagulation thrombotic thrombotic event Trial Venous Thromboembolism with COVID-19 World Health Organization [DOI] 10.1016/j.ahj.2021.04.005 PMC 바로가기 [Article Type] Clinical Trial
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trialRandomized Controlled Trial Published on 2021-06-122022-10-05 Journal: Lancet (London, England) [Category] SARS, 임상, [키워드] 1:1 absence allergic reaction analysed Analysis anticoagulation assigned Bayer bleeding blinded Brazil clinical outcomes clinically Coalition Concentration Controlled trial COVID-19 COVID-19 symptom D-dimer death duration of hospitalisation Efficacy Efficacy and safety elevated Follow-up Hierarchical hospital hospitalised IMPROVE improve clinical outcome In-hospital initial intention-to-treat population intravenous medication multicentre not different occurred one patient Open-label Oral anticoagulants outcome Patient patients per day Pragmatic primary analysis Prophylactic prophylactic anticoagulation prothrombotic state randomisation randomised Randomly receive reflect Registered risk screened Seven supplemental oxygen therapeutic therapeutic anticoagulation unfractionated heparin with COVID-19 withdrawal of consent [DOI] 10.1016/S0140-6736(21)01203-4 PMC 바로가기 [Article Type] Randomized Controlled Trial
Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-seriesCOVID-19와 급성 신장 손상이 있는 중환자에서 CytoSorb 카트리지를 추가하여 지속적인 신대체 요법: 사례 시리즈Article Published on 2021-05-012022-09-11 Journal: Artificial organs [Category] MERS, SARS, 바이오마커, [키워드] 95% CI acute kidney Acute kidney injury acute respiratory distress acute respiratory distress syndrome addition Admission AKI Analysis analyzed Antibiotics anticoagulation APACHE ARDS arterial pressure assessment body mass body mass index C-reactive protein cartridge chronic Concentration Continuous Continuous renal replacement therapy continuous renal replacement therapy with cytosorb COVID-19 COVID-19 patient Critically ill critically ill COVID-19 patients Critically ill patient CRRT CRS cutoff point Cytokine release syndrome Cytosorb D-dimers Duration enrolled ferritin function Hospital mortality Hydrocortisone hyperinflammation ICU ICU admission in-hospital mortality inflammatory biomarkers intensive care interferon interferon beta Interferon beta-1b interleukin interleukin-6 Lactate lactate dehydrogenase life-threatening lymphocyte Lymphocyte count lymphocyte counts male mechanical ventilation Mortality nonsurvivors organ function oxygen Oxygenation PaO Patient Physiology predicted prone positioning Prophylactic prophylactic anticoagulation provided Pulmonary emboli renal replacement therapy replacement therapy respiratory distress Respiratory distress syndrome retrospective ribavirin Safe Sepsis Septic shock Shock Side effect SOFA SOFA scores survivor Survivors syndrome therapy Thromboembolism Ventilation were recorded with COVID-19 [DOI] 10.1111/aor.13864 PMC 바로가기 [Article Type] Article
Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 PatientsConference abstract Published on 2021-02-062022-10-05 Journal: Blood [Category] 치료법, [키워드] 95% CI Accuracy Adjusting African American age Analysis analyzed anticoagulation BMI CDC Coagulopathy complications COVID-19 COVID-19 patient decrease demographics described discharge download DVT Endothelial dysfunction event figure Frame Gender global pandemic Hispanic patient Hospitalized hospitalized COVID-19 patient hospitalized patient hospitalized patients Impact incidence incidence of COVID-19 include inflammatory state less lowest morbidity and mortality Mortality mortality rate no difference Non-COVID-19 Non-pulmonary occurred outcome Patient patient population patients patients with COVID-19 patients with PE positive pro-inflammatory state Prophylactic prophylactic anticoagulation Prophylaxis prothrombotic state reduce reported respiratory compromise Result resulting Retrospective analysis severe COVID-19 severe disease severe inflammation significantly significantly higher specific treatment steroid Steroids stroke therapeutic therapeutic anticoagulation Thromboembolism thrombosis thrombotic event Treatment Trial VTE was performed with COVID-19 [DOI] 10.1182/blood-2020-137707 [Article Type] Conference abstract